National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.

ORLADEYO net revenue expected to be between $515-$535 million in 2025— —Total revenue (including RAPIVAB®) expected to be ...

Following a fresh round of job cuts in December, CDMO National Resilience is carrying its downsizing efforts into 2025. | ...

D.R. Horton (NYSE: DHI) recently paid $4.475 million for an office building on Meridian Parkway near Research Triangle Park, ...

In May, Howell became CEO of Parexel, one of the world’s largest clinical research organizations, an industry that has a ...

These corporate policies will affect work-life balance, talent recruitment, the economic health of downtowns, and real estate ...

National Reliance Inc., which focuses on biologics, vaccines, and gene therapies, is expected to keep the Triangle office open after the cuts.

From Apple to NCInnovation, Trump tariffs to driverless cars, here are the 25 questions to keep tabs on in the new year.

It might also be the Triangle’s fastest-growing major employer. The company has more than 8,000 employees in North Carolina, with most based at its Research Triangle Park campus. In September ...

"It is hard to live in a constant battle between two people who once thought building a life together was a good idea," ...

North Carolina is one of the top states for issuing those visas, and much of that is due to tech companies in the Triangle. "At Research Triangle Park, whether you're looking at SAS, GSK ...